Literature DB >> 30378048

Generation and Culture of Tumor and Metastatic Organoids from Murine Models of Pancreatic Ductal Adenocarcinoma.

Lindsey A Baker1,2, David A Tuveson3,4.   

Abstract

Pancreatic ductal adenocarcinoma (PDA) is a lethal malignancy that is refractory to all current therapies. Research into the mechanisms driving this cancer is the key to developing better diagnostic and treatment options which are urgently needed in the clinic. Genetically engineered mouse models of PDA have been valuable research tools, enabling studies of all stages of PDA progression. However, these models are difficult and time-consuming to breed, and engineering further mutations into these models requires additional time. Recently, organoid cultures of PDA have emerged as alternative models for this disease. Organoids can be rapidly generated from mouse models of PDA and enable genetic and biochemical perturbation of all stages of PDA progression. Here, we describe the generation and propagation of organoid models from PDA tumors and metastases harvested from genetically engineered mouse models.

Entities:  

Keywords:  3D culture; Cancer models; Organoids; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Tumoroids

Mesh:

Year:  2019        PMID: 30378048     DOI: 10.1007/978-1-4939-8879-2_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Matrix stiffness mediates pancreatic cancer chemoresistance through induction of exosome hypersecretion in a cancer associated fibroblasts-tumor organoid biomimetic model.

Authors:  Weikun Xiao; Mahsa Pahlavanneshan; Chae-Young Eun; Xinyu Zhang; Charlene DeKalb; Bayan Mahgoub; Hanaa Knaneh-Monem; Sana Shah; Alireza Sohrabi; Stephanie K Seidlits; Reginald Hill
Journal:  Matrix Biol Plus       Date:  2022-05-16

2.  Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma.

Authors:  Louise M Fanchon; James Russell; Nagavarakishore Pillarsetty; Isabella O'Donoghue; Kishore Gangangari; Kenneth H Yu; John L Humm
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.